Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 136–150 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3505 CEP290 Gene Sequencing Test for Bardet-Biedl Syndrome Type 14 This test identifies pathogenic variants in the CEP290 gene, which are associated with Bardet-Biedl syndrome type 14, a rare genetic disorder.	Whole Blood, Extracted DNA, or FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEP290 gene pathogenic variants", "Coding exons", "Splice-site junctions", "Intronic coverage"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical features suggestive of Bardet-Biedl syndrome", "Family history of Bardet-Biedl syndrome", "Carrier testing for first-degree relatives"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the CEP290 gene, which are associated with Bardet-Biedl syndrome type 14, a rare genetic disorder.
TEST-6275 CETP Gene Hyperalphalipoproteinemia Genetic Test This genetic test evaluates the CETP gene for variants associated with familial hyperalphalipoproteinemia (elevated HDL-C). It identifies mutations that may alter cardiovascular ri...	Peripheral Whole Blood, Saliva, or FTA Card Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CETP gene variants", "HDL-C predisposition"] Parameters [] Preparation ["No special preparation required", "Inform phlebotomist of anticoagulant medications"] Indications ["Familial hyperalphalipoproteinemia", "Elevated HDL-C levels", "Cardiovascular risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21776-5 ICD-10: E78.8 Clinical summary This genetic test evaluates the CETP gene for variants associated with familial hyperalphalipoproteinemia (elevated HDL-C). It identifies mutations that may alter cardiovascular risk profiles.
TEST-5553 CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test This genetic test identifies pathogenic variants in the CFAP298 gene associated with primary ciliary dyskinesia type 26 (PCD26).	Whole blood (EDTA), Extracted DNA, FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFAP298 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor.", "Inform the team if you have received a whole blood transfusion or allogeneic bone marrow transplant within the last 90 days."] Indications ["Diagnosis of primary ciliary dyskinesia type 26 (PCD26)", "Individuals with clinical features suggestive of PCD26"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q34.8 Clinical summary This genetic test identifies pathogenic variants in the CFAP298 gene associated with primary ciliary dyskinesia type 26 (PCD26).
TEST-3820 CFH Gene Hemolytic Uremic Syndrome Genetic Test This test evaluates the CFH gene for mutations associated with atypical hemolytic uremic syndrome (aHUS).	Peripheral whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFH gene mutations", "Point mutations", "Small indels", "Copy number variants (CNV)"] Parameters [] Preparation ["No fasting required", "No medication cessation required unless advised by doctor", "Provide detailed family medical history", "List of current medications"] Indications ["Suspected atypical hemolytic uremic syndrome (aHUS)", "Family history of aHUS", "Need for genetic risk assessment for aHUS"] Measurement technique Confirm with laboratory Codes LOINC: 21661-6 ICD-10: D59.3 Clinical summary This test evaluates the CFH gene for mutations associated with atypical hemolytic uremic syndrome (aHUS).
TEST-4107 CFL1 Gene (Corticobasal Degeneration) Genetic Test This test evaluates the CFL1 gene for pathogenic variants associated with corticobasal degeneration.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFL1 gene", "Single nucleotide variants", "Insertions/Deletions", "Copy number alterations"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory", "Provide detailed family history", "Consent required from patient or legal guardian"] Indications ["Suspected corticobasal degeneration based on clinical presentation", "Family history of CBD or related neurodegenerative disorders", "Differential diagnosis of parkinsonism"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G31.85 Clinical summary This test evaluates the CFL1 gene for pathogenic variants associated with corticobasal degeneration.
TEST-5293 CHAT Gene Congenital Myasthenic Syndrome Genetic Test This genetic test analyzes the CHAT gene for mutations associated with congenital myasthenic syndrome.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHAT gene sequence", "Pathogenic variants in CHAT gene"] Parameters [] Preparation ["No special preparation needed", "Mandatory genetic counseling session required"] Indications ["Clinical suspicion of congenital myasthenic syndrome", "Family history of congenital myasthenic syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 95810-1 ICD-10: G70.2 Clinical summary This genetic test analyzes the CHAT gene for mutations associated with congenital myasthenic syndrome.
TEST-2008 CHEK2 Gene Li‑Fraumeni Syndrome Type 2 Genetic Test This genetic test evaluates the CHEK2 gene for variants associated with an increased risk of developing certain cancers, particularly hereditary breast, colorectal, and prostate ca...	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHEK2 gene variants", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a personal or family history suggestive of hereditary cancer syndromes", "Assessment of cancer predisposition", "Guiding personalized cancer screening and prevention strategies"] Measurement technique Confirm with laboratory Codes LOINC: 92930-2 ICD-10: Z15.09 Clinical summary This genetic test evaluates the CHEK2 gene for variants associated with an increased risk of developing certain cancers, particularly hereditary breast, colorectal, and prostate cancers.
TEST-3602 CHN1 Gene Sequencing for Duane Retraction Syndrome Test This test analyzes the CHN1 gene for pathogenic variants associated with Duane retraction syndrome.	Peripheral whole blood (5 ml in EDTA tube) or saliva (Oragene kit)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHN1 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected Duane retraction syndrome", "Family history of Duane retraction syndrome", "Need for genetic counseling regarding recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: H50.81 Clinical summary This test analyzes the CHN1 gene for pathogenic variants associated with Duane retraction syndrome.
TEST-2395 CHRM3 Gene (Prune Belly Syndrome) Genetic Test This test evaluates the CHRM3 gene for pathogenic variants associated with Prune Belly Syndrome.	Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHRM3 gene", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy number changes"] Parameters [] Preparation ["No fasting required.", "No medication changes required."] Indications ["Diagnosis confirmation of Prune Belly Syndrome", "Family planning", "Paediatric surgical planning"] Measurement technique Confirm with laboratory Codes LOINC: 86654-1 ICD-10: Q79.4 Clinical summary This test evaluates the CHRM3 gene for pathogenic variants associated with Prune Belly Syndrome.
TEST-4436 CHRNB2 Gene Epilepsy (Nocturnal Frontal Lobe Type 3) Genetic Test This genetic test identifies pathogenic variants in the CHRNB2 gene associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).	EDTA whole blood or FTA card	3–4 weeks (expedited clinical reporting)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHRNB2 gene", "Molecular diagnosis of ADNFLE"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9% (detects SNVs, indels, and deep intronic splicing variants)"}, {"name": "Methodology", "reference_range": "NGS plus optional RNA-Seq (full exon-level resolution)"}] Preparation ["No special preparation required", "Inform phlebotomist of medications, especially anticoagulants"] Indications ["Suspected Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)", "Confirmation of molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94862-1 ICD-10: G40.0 Clinical summary This genetic test identifies pathogenic variants in the CHRNB2 gene associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).
TEST-4785 CHRND Gene Lethal Multiple Pterygium Syndrome Genetic Test This test evaluates the CHRND gene for pathogenic variants associated with lethal multiple pterygium syndrome (LMPS). It identifies mutations that cause this severe congenital diso...	Peripheral Blood (Whole Blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHRND gene pathogenic variants", "Lethal Multiple Pterygium Syndrome (LMPS) risk"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during active infection"] Indications ["Diagnosis of suspected LMPS", "Carrier screening for LMPS", "Prenatal diagnosis of LMPS"] Measurement technique Confirm with laboratory Codes LOINC: 55225-7 ICD-10: Q87.0 Clinical summary This test evaluates the CHRND gene for pathogenic variants associated with lethal multiple pterygium syndrome (LMPS). It identifies mutations that cause this severe congenital disorder.
TEST-5359 CIITA Gene Test This genetic test evaluates the CIITA gene for mutations causing Bare Lymphocyte Syndrome Type II (BLS II), a severe primary immunodeficiency.	Whole Blood (EDTA) or FTA Card (finger-prick for paediatric)	21–28 Calendar Days (Expedited 14 days available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CIITA gene sequence (coding exons, splice-site junctions)", "Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number variations (CNVs)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}, {"name": "Analytical Sensitivity", "reference_range": ">99.8%"}, {"name": "Gene Coverage", "reference_range": "Full Gene Coverage (Exons + Splice Sites + CNV)"}] Preparation ["No specific fasting required", "Inform lab of any known EDTA or latex allergies"] Indications ["Suspected Bare Lymphocyte Syndrome Type II (BLS II)", "Recurrent opportunistic infections (e.g., Pneumocystis jirovecii pneumonia, persistent candidiasis)", "Severe eczema unresponsive to standard therapy", "Hypogammaglobulinemia", "Absent HLA-DR expression on flow cytometry"] Measurement technique Confirm with laboratory Codes LOINC: 81247-8 ICD-10: D81.6 Clinical summary This genetic test evaluates the CIITA gene for mutations causing Bare Lymphocyte Syndrome Type II (BLS II), a severe primary immunodeficiency.
TEST-5468 CISD2 Gene (Wolfram Syndrome Type 2) Genetic Test This test identifies pathogenic variants in the CISD2 gene associated with Wolfram syndrome type 2.	Peripheral Whole Blood (EDTA)	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CISD2 gene", "Coding region and splice sites of the CISD2 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with clinical features suggestive of Wolfram syndrome type 2", "Family cascade screening for relatives of affected individuals", "Carrier screening in families with a known history of WFS2"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E13.8 Clinical summary This test identifies pathogenic variants in the CISD2 gene associated with Wolfram syndrome type 2.
TEST-4084 CITED2 Gene Ventricular Septal Defect Type 2 Genetic Test This genetic test evaluates the CITED2 gene for variants associated with Ventricular Septal Defect Type 2.	Whole Blood (Venipuncture), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CITED2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Maintain prescribed therapies unless directed otherwise by physician", "Coordinate test timing and medication adjustments with cardiologist"] Indications ["Suspected or confirmed Ventricular Septal Defect Type 2", "Family history of VSD2", "Genetic counseling for congenital heart disease"] Measurement technique Confirm with laboratory Codes LOINC: 81677-8 ICD-10: Q21.0, Z15.09, Z82.79 Clinical summary This genetic test evaluates the CITED2 gene for variants associated with Ventricular Septal Defect Type 2.
TEST-2947 CLCF1 Gene Cold-Induced Sweating Syndrome Type 2 Genetic Test This test identifies pathogenic variants in the CLCF1 gene associated with Cold-Induced Sweating Syndrome Type 2.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLCF1 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Cold-Induced Sweating Syndrome Type 2", "Documented family history of the disorder", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 101578-7 ICD-10: Q87.8, G90.8 Clinical summary This test identifies pathogenic variants in the CLCF1 gene associated with Cold-Induced Sweating Syndrome Type 2.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.